Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07429838Phase 1Not Yet Recruiting

EGEN-5784 Porcine Liver With the Metra® ELC Device

Role: collaborator

NCT04483102Not ApplicableActive Not Recruiting

RESTORE Declined Livers Study

Role: collaborator

NCT04862156Not ApplicableTerminated

WP02 Continued Access Study

Role: lead

NCT05526326Completed

OrganOx Metra® New Enrollment PAS

Role: lead

NCT02775162Not ApplicableCompleted

WP01 - Normothermic Liver Preservation

Role: lead

All 5 trials loaded